Poly Medicure
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Poly Medicure is strategically transitioning from a volume-driven infusion therapy provider to a diversified global medical device platform, focusing on high-growth segments such as cardiology and renal care. Management's emphasis on integrating recent European acquisitions and expanding into emerging markets like Brazil is expected to enhance revenue streams, despite short-term margin pressures due to acquisition-related costs and logistical challenges. Vista's financial outlook anticipates stable revenue growth aligned with historical performance, although margins may face continued pressure. The company's low leverage supports financial stability, while the fair valuation reflects its intrinsic value. Industry dynamics, including the growing demand for contract manufacturing and the shift towards Indian CDMOs, provide a favorable backdrop for Poly Medicure's expansion. Over the next 12-24 months, key opportunities include leveraging India's manufacturing cost advantage and a robust product pipeline, while watchpoints include successful integration of acquisitions and managing raw material volatility
Why We Like This Stock
- Management's focus on high-growth segments and successful integration of European acquisitions is expected to drive long-term revenue growth
- The company's strong R&D capabilities and commitment to value-based pricing enhance its competitive position in the market
- Low leverage and a conservatively financed balance sheet provide financial stability amid expansion efforts
Things To Watch Out For
- Short-term margin pressures due to acquisition integration and high capital expenditures may impact profitability
- Logistical disruptions in West Asia and raw material price volatility pose risks to operational efficiency
- Regulatory compliance across multiple jurisdictions presents ongoing challenges for the company's expansion strategy
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 1,375 | 1,669 | 1,875 | 2,053 | 2,333 |
| Profit Before Tax (Cr.) | 345 | 447 | 534 | 501 | 593 |
| PBT Margin | 25.1% | 26.8% | 2848.0% | 24.4% | 25.4% |
| Net Profit (Cr.) | 267 | 352 | 332 | 381 | 451 |
| Earnings Per Share | 26.4 | 34.8 | 32.8 | 37.6 | 44.5 |
Analyst Recommendations
No analyst recommendations available.
Company Overview
Show Company Profile
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, such as blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, foley balloon and urine drainage catheters, and urine collection bags with measured volume meters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.